Patents by Inventor Ezra R. Lowe

Ezra R. Lowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMISELIMOD FOR PREVENTING, TREATING OR AMELIORATING ULCERATIVE COLITIS
    Publication number: 20240299318
    Abstract: Described herein are methods for treating, ameliorating, and/or preventing ulcerative colitis (UC) as well as other inflammatory gastrointestinal disorders using amiselimod. The method of treatment includes dosing amiselimod at a larger initial dose as compared to the eventual maintenance dose.
    Type: Application
    Filed: February 8, 2022
    Publication date: September 12, 2024
    Inventors: Jimin Lee, Neal Slatkin, Ezra R. Lowe, Zeev Heimanson
  • TARGETED RELEASE RIFAXIMIN COMPOSITIONS
    Publication number: 20230277447
    Abstract: Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.
    Type: Application
    Filed: June 25, 2021
    Publication date: September 7, 2023
    Applicant: Bausch Health Ireland Limited
    Inventors: Jacob Cole, Brian R. Rohrs, Daniel J. Stein, Robert J. Israel, Ezra R. Lowe
  • METHODS OF USING RIFAMYCIN SV FOR THE TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20220280478
    Abstract: Provided herein is the use of rifamycin SV the treatment of sickle cell disease (SCD).
    Type: Application
    Filed: March 4, 2022
    Publication date: September 8, 2022
    Applicant: Bausch Health Ireland, Limited
    Inventors: Ezra R. Lowe, Zeev Heimanson